PriceTargets.com logo

Chimera Investment - CIM Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.25
  • Forecasted Upside: 18.78%
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$12.84 As of 12/4/2025 04:59 PM ET
▼ -0.121 (-0.93%)

This chart shows the closing price for CIM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Chimera Investment Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CIM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CIM

Analyst Price Target is $15.25
▲ +18.78% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Chimera Investment in the last 3 months. The average price target is $15.25, with a high forecast of $15.50 and a low forecast of $15.00. The average price target represents a 18.78% upside from the last price of $12.84.

This chart shows the closing price for CIM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 contributing investment analysts is to hold stock in Chimera Investment. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
11/25/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
11/19/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
11/18/2025UBS GroupLower TargetBuy ➝ Buy$16.00 ➝ $15.50
11/7/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
7/10/2025UBS GroupBoost TargetBuy ➝ Buy$15.00 ➝ $16.00
7/10/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$16.50 ➝ $15.00
5/14/2025UBS GroupUpgradeNeutral ➝ Buy$11.50 ➝ $15.00
3/14/2025Royal Bank Of CanadaUpgradeModerate Buy
1/23/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
8/8/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$15.00 ➝ $16.00
7/10/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ Market Perform$15.00 ➝ $15.00
12/6/2023UBS GroupInitiated CoverageNeutral$16.50
5/19/2023Credit Suisse GroupLower Target$19.50 ➝ $16.50
3/9/2023Credit Suisse GroupReiterated RatingNeutral$19.50
3/7/2023Royal Bank Of CanadaReiterated RatingOutperform$21.00
10/13/2022Credit Suisse GroupLower Target$22.50
10/5/2022Royal Bank Of CanadaLower TargetOutperform$33.00 ➝ $21.00
7/22/2022Credit Suisse GroupLower Target$28.50
7/18/2022BarclaysLower TargetUnderweight$33.00 ➝ $27.00
4/27/2022BarclaysLower Target$42.00 ➝ $33.00
1/10/2022BarclaysBoost TargetUnderweight$33.00 ➝ $42.00
10/27/2021BTIG ResearchReiterated RatingHold
4/23/2021BTIG ResearchReiterated RatingHold
2/22/2021Raymond James FinancialReiterated RatingHold
12/10/2020BarclaysDowngradeEqual Weight ➝ Underweight$27.00 ➝ $30.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.87 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 5 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/9/2025
  • 17 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 8 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 7 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 11 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 10 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 7 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 10 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 10 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Chimera Investment logo
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities. It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $12.84
Low: $12.79
High: $12.95

50 Day Range

MA: $12.72
Low: $11.73
High: $13.69

52 Week Range

Now: $12.84
Low: $9.85
High: $15.37

Volume

623,051 shs

Average Volume

772,442 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

11.42%

Beta

1.83

Frequently Asked Questions

What sell-side analysts currently cover shares of Chimera Investment?

The following sell-side analysts have issued research reports on Chimera Investment in the last year: JMP Securities, Keefe, Bruyette & Woods, Royal Bank Of Canada, UBS Group AG, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for CIM.

What is the current price target for Chimera Investment?

0 Wall Street analysts have set twelve-month price targets for Chimera Investment in the last year. Their average twelve-month price target is $15.25, suggesting a possible upside of 18.8%. UBS Group AG has the highest price target set, predicting CIM will reach $15.50 in the next twelve months. Keefe, Bruyette & Woods has the lowest price target set, forecasting a price of $15.00 for Chimera Investment in the next year.
View the latest price targets for CIM.

What is the current consensus analyst rating for Chimera Investment?

Chimera Investment currently has 1 sell rating, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CIM, but not buy more shares or sell existing shares.
View the latest ratings for CIM.

What other companies compete with Chimera Investment?

Other companies that are similar to Chimera Investment include AGNC Investment, ARMOUR Residential REIT, Dynex Capital, Ellington Financial and Ladder Capital. Learn More about companies similar to Chimera Investment.

How do I contact Chimera Investment's investor relations team?

Chimera Investment's physical mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust's listed phone number is (888) 895-6557 and its investor relations email address is [email protected]. The official website for Chimera Investment is www.chimerareit.com. Learn More about contacing Chimera Investment investor relations.